Country: Ástralía
Tungumál: enska
Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CLOSTRIDIUM TETANI UF TOXOID; THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
Cl tetani - toxoid
MISC. VACCINES OR ANTI SERA
CLOSTRIDIUM TETANI UF TOXOID VACCINE-TOXOID Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml
10mL Vial; 1mL Syr
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CATTLE | DOG | GOAT | HORSE | PIGS | SHEEP | BEEF | BILLY | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUCK | BUFFALO |
IMMUNOTHERAPY
TETANUS | TETANUS VACCINATION
Poison schedule: 0; Withholding period: WHP: Meat:Nil Milk:Nil; Host/pest details: CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; For the immunisation of horses, dogs, cattle, sheep, goats and pigs against tetanus.
Registered
2023-07-01
AUSTRALIAN GOVERNMENT Australian Pesticides and Veterinary Medicines Authority APPENDIX 2 TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS) (VETERINARY PRODUCTS) Select appropriate: 13 New Product (include all applicable RLPs) OR Er Variation (highlight instructions that are being varied). Approval no. of label being varied: 51772/0306. Signal heading: FOR ANIMAL TREATMENT ONLY Product name: Equivac® T Vaccine Active constituent/s: Equivac T is a purified adjuvanted vaccine containing the formalinised toxin of Clostridium tetani (20 Lf/mL) The adjuvant, which is an aluminium salt, increases the level and duration of the immunity afforded by the vaccine. The type of adjuvant and the purification procedures used ensure maximum protection of animals with minimum risk of local reactions at the site of injection. Thiomersal 0.1 mg/mL is added as a preservative. Statement of claims: For the immunisation of horses, dogs, cattle, sheep, goats and pigs against tetanus. Net contents: 1mL dose syringe. 10mL dose vial. Directions for Use Heading: "AK\ 4,10. RLP Approved DIRECTIONS FOR USE READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT Contents must be left in outer package until immediately before use Shake well before use and keep thoroughly mixed during use Use all product within 12 hours of opening. It is important that the vaccine is kept properly mixed before and during use. There may be settling of the adjuvant after storage but material is easily resuspended by inversion of the syringe or vial. Before vaccine is injected, the proposed site of inoculation on the animal's skin may be cleaned by swabbing with cotton-wool soaked in a suitable antiseptic solution, such as methylated spirits. Restraints: N/A Contraindications: N/A Precautions: N/A Side effects: Localised swelling may develop at the site of injection and a firm nodular lump may persist for some weeks or even months. There may be temporary lameness. Allergic reactions such as anaphlylaxis occur rarely with all vaccines and may require appropriate treatment Lestu allt skjalið
PRODUCT NAME: EQUIVAC ® T VACCINE PAGE: 1 OF 5 THIS REVISION ISSUED: MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Saline suspension of vaccine ingredients. TRADE NAME: EQUIVAC ® T VACCINE PFIZER MSDS CODE: 0343 PRODUCT USE: Vaccine for the prevention of tetanus in horses, dogs, cattle, sheep, goats and pigs CREATION DATE: AUGUST, 2004 THIS VERSION ISSUED: APRIL 2010 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: None allocated. (NZ S2) ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Aqueous liquid suspension. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be mil Lestu allt skjalið